Atypical Hemolytic Uremic Syndrome Market To Reach New Heights In Growth By 2034, Delveinsight Predicts
Atypical Hemolytic Uremic Syndrome market Forecast. DelveInsight's Atypical Hemolytic Uremic Syndrome Market report offers an in-depth understanding of the ...
Apellis Pharmaceuticals CFO sells $16,119 in stock
Timothy Eugene Sullivan, the Chief Financial Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.76 billion market ...
Apellis Pharmaceuticals officer sells shares for $10,776
In a recent transaction involving Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), Mark Jeffrey DeLong, the company's Chief Business & Strategy Officer, sold 365 shares of common stock. The shares were ...